CD4 and non-small cell lung carcinoma: In NSCLC, ovarian and nasopharyngeal cancers, CXCL13-producing CD4+ T cells within the TME are predominantly localized at the core of TLS, display a Tfh cell phenotype, and function as potentiators of antitumor immunity [76,77,78].